Application
Western blot analysis of extracts from K562 cells untreated or treated with H2O2 using Bcr(Phospho-Tyr177) AntibodyApplication
Immunohistochemical analysis of paraffin-embedded human tonsil tumor tissue using Bcr (Phospho-Tyr177) Antibody (left) or the same antibody preincubated with blocking peptide (right).Application
Western blot analysis of extracts from K562 cells untreated or treated with H2O2 using Bcr (Phospho-Tyr177) Antibody .| Product Name | Bcr (phospho Tyr177) antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit Polyclonal antibody to Bcr (Phospho Tyr177)GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity. |
| Immunogen | Peptide sequence around phosphorylation site of tyrosine 177 (P-F-Y(p)-V-N) derived from Human Bcr. |
| Modification | p-Tyr177 |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | IHC-PWB |
| Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | ALL BCR1 CML D22S11 D22S662 FLJ16453 PHL BCR breakpoint cluster region protein renal carcinoma antigen NY-REN-26 breakpoint cluster region |
|---|---|
| Target | Bcr (Phospho Tyr177) |
| Molecular Weight(MW) | 210 (note) |
Application
Western blot analysis of extracts from K562 cells untreated or treated with H2O2 using Bcr(Phospho-Tyr177) Antibody
Application
Immunohistochemical analysis of paraffin-embedded human tonsil tumor tissue using Bcr (Phospho-Tyr177) Antibody (left) or the same antibody preincubated with blocking peptide (right).
Application
Western blot analysis of extracts from K562 cells untreated or treated with H2O2 using Bcr (Phospho-Tyr177) Antibody .| Application Notes | Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
